Compound information
- Natural Products
- ZC464291
- Molecular Formula
- C14H20N2O3
- Molecular Weight
- 264.1473925 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-carbamoyl-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C14H20N2O3/c1-10(2)8-12(13(15)17)16-14(18)19-9-11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3,(H2,15,17)(H,16,18)/t12-/m0/s1
- InChI Key
- JZEYMGMOBIYUOV-LBPRGKRZSA-N
- SMILES
- CC(C)C[C@H](NC(=O)OCc1ccccc1)C(N)=O
- Source
- ZINC000002571885
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 81.42 Å2 | LogP | 1.915 |
LogS | -2.875 | LogD | 2.574 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.025 | Pgp substrate | 0.073 |
HIA | 0.963 | F20 % | 0.994 |
F30 % | 0.727 | Caco-2 | -4.924 |
MDCK | -4.61 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.976 | PPB | 74.686 |
VD | 0.564 | Fu | 0.859 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.042 | CYP1A2 substrate | 0.744 |
CYP2A6 substrate | 0.461 | CYP2B6 substrate | 0.522 |
CYP2C19 inhibitor | 0.39 | CYP2C19 substrate | 0.928 |
CYP2C8 substrate | 0.789 | CYP2C9 inhibitor | 0.096 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.016 |
CYP2D6 substrate | 0.414 | CYP2E1 substrate | 0.226 |
CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.984 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.662 | CL | 7.576 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.929 |
Mutagenicity | 0.213 | Rat Oral Acute Toxicity | 0.023 |
FDAMDD | 0.054 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.229 | Eye Corrosion | 0.003 |
Eye Irritation | 0.067 | Respiratory Toxicity | 0.003 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.056 | IGC50 | 2.785 |
LC50FM | 3.496 | LC50DM | 4.844 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.097 | NR-AR-LBD | 0.206 |
NR-AhR | 0.004 | NR-Aromatase | 0.054 |
NR-ER | 0.238 | NR-ER-LBD | 0.292 |
NR-PPAR-gamma | 0.262 | SR-ARE | 0.029 |
SR-ATAD5 | 0.352 | SR-HSE | 0.12 |
SR-MMP | 0.009 | SR-p53 | 0.015 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.